Acadia Pharmaceuticals | ACAD - 贸易债权人

金融业

USD

USD 1.61B

现金及等价物

USD 851.46M

USD 24.79M

USD 1.1B

USD 305.52M

USD 52.19M

USD -4.62M

USD 20.32M

653

EPS每股收益

USD 0.02

股本和储备

USD 1.25B

USD 243.27M

债务利息支出

USD 0

USD 8.33M

USD 0

USD 3.56B

USD 3.64M

USD 272.68M

USD -4.62M

普通股股本

USD 169.18M

10.08

USD 3.98M

USD 268.06M

销售和管理费用

USD 160.79M

USD 31.57M

贸易债权人

USD 12.25M

应收帐款人

USD 148.38M

	贸易债权人	更改		日
Acadia Pharmaceuticals	USD 12.25M		1.34M	2026-03
ALKERMES	USD 102.36M		5.59M	2026-03
Alnylam Pharmaceuticals	USD 126.63M		10.91M	2026-03
Biogen	USD 358.5M		73.5M	2026-03
BioMarin Pharmaceutical	USD 793.15M		34.12M	2026-03
Bristol-Myers Squibb	USD 4.23B		659M	2026-03
Cara Therapeutics	USD 3.22M		859K	2025-12
Corcept Therapeutics	USD 33.31M		7.14M	2026-03
Cytokinetics	USD 24.71M		80.91M	2026-03
Eisai	JPY 75.89B		9.6B	2026-03
Eli Lilly	USD 5.03B		350M	2026-03
Incyte	USD 228.62M		1.41B	2026-03
J&J	USD 10.46B		1.53B	2026-03
Moderna	USD 161M		156M	2026-03
Neurocrine Biosciences	USD 691.3M		145.8M	2026-03
Pfizer	USD 4.51B		734M	2026-03
Prothena	USD 4.3M		1.58M	2026-03
PTC Therapeutics	USD 25.48M		20M	2026-03
Sarepta Therapeutics	USD 70.38M		210.46M	2026-03
Ultragenyx Pharmaceutical	USD 42M		11M	2026-03
Vanda Pharmaceuticals	USD 39.09M		33.28M	2024-12
Vertex Pharmaceuticals	USD 3.47B		40.6M	2026-03